iShares NASDAQ Biotechnology ETF
ALTAR
Score™		 0.5% info Recommen-
dation		 AVOID
2020E    2021E
P/E
ratio		 97.8x P/Sales
ratio		 6.9x
P/BV
ratio		 5.7x Div.
yield		 0.7%


  • Description
  • Performance
  • Comps
  • premium Fundamentals
  • premium Valuation
  • premium Rating
The iShares Nasdaq Biotechnology Index Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of companies primarily engaged in the biotechnology industry, as represented by the NASDAQ Biotechnology Index.

FUND BASICS
Category US Equities
Fund Sponsor Barclays Global Investors
Website www.ishares.com
Inception date Feb 05, 2001
Assets (mns) $9,152
Currency USD
Expense ratio 46 bp
Distributions Quarterly

FUND STRUCTURE
Regulation Open-Ended Fund
Custodian State Street Bank & Trust
Weighting Market Cap
Index replication n/a
Uses derivatives No
Options available Yes

SECTOR BREAKDOWN

 


CONSTITUENT BREAKDOWN
No. of constituents 204
Wgt avg mkt cap (mns) $38,693
Large cap (>$10bn) 58.0%
Mid cap ($2-10bn) 29.2%
Small cap (<$2bn) 12.5%
Developed mkts 99.0%
Emerging mkts 0.9%

TOP TEN HOLDINGS
AMGEN INC 7.3 %
GILEAD SCIENCES INC 7.3 %
REGENERON PHARMACEUTICALS 6.3 %
VERTEX PHARMACEUTICALS INC 5.8 %
ILLUMINA INC 4.9 %
BIOGEN IDEC INC 3.7 %
SEATTLE GENETICS INC 3.6 %
MODERNA, INC. 3.0 %
ALEXION PHARMACEUTICALS INC 2.9 %
IMMUNOMEDICS INC 2.1 %
Total 46.8 %

TOP COUNTRY EXPOSURE
UNITED STATES 86.9 %
IRELAND 3.2 %
BRITAIN 2.6 %
CHINA 2.3 %
FRANCE 1.1 %
DENMARK 0.9 %
NETHERLANDS 0.9 %
SWITZERLAND 0.8 %
SPAIN 0.3 %
CANADA 0.2 %

HISTORICAL PERFORMANCE info

  Custom date range Compare to  
  thru


Standardized Annual Returns (thru September 30)
Year-to-date 1 year 5 years 10 years Since Incep.
12.6% 36.4% 6.3% 17.0% 7.8%

Market Correlations
versus... Beta R-squared
S&P500 0.92 52%
MSCI EAFE 0.90 41%
MSCI Emg. Mkts. 0.66 35%

Technical Indicators
Recent close $134.19
30d moving avg. $136.39
Annualized volatility 22.6%
Short interest (ETF) 31.3%
Short interest (Underlying) 5.2%
Relative strength (RSI) 54

Liquidity measures
Avg. volume (thou.) 3,129
Turnover 4.6%
Bid/Ask (% of price) 0.02%
ADV underlying (mns) $10,483

Distributions


FINDING ALTERNATIVE FUNDS

Below is a list of 100 potential alternatives to the iShares NASDAQ Biotechnology ETF ETF based on the alternatives' overlap in portfolio holdings with IBB. Consider funds with lower expense ratios and/or higher ALTAR Score™ ratings as possible alternatives.

Benchmark ticker: IBB Expense: 46 bp ALTAR Score™: 0.5%


ALTERNATIVE ETFs BASED ON OVERLAP WITH IBB
Ticker Fund
Name		 Overlap1
vs IBB
(%)		 Expense
ratio
(bp)		 Savings
vs IBB
(bp)		 ALTAR
Score™
(%)		 ALTAR
vs IBB
(%)
BBH VanEck Vectors Biotech ETF 53.9 35 11 4.0 +3.4
IEIH iShares Evolved U.S. Innovative Healthcare ETF 52.6 18 28 3.3 +2.8
BTEC Principal Healthcare Innovators Index ETF 42.3 42 4 -2.2 -2.8
FBT First Trust NYSE Arca Biotechnology Index Fund 39.2 55 -9 -1.0 -1.5
XBI SPDR S&P BIOTECH ETF 35.6 35 11 -2.2 -2.7
IBBJ Defiance Nasdaq Junior Biotechnology ETF 33.8 45 1 -2.1 -2.6
PBE Invesco Dynamic Biotechnology & Genome ETF 33.1 58 -12 -2.5 -3.1
BMED BlackRock Future Health ETF 22.7 85 -39 -1.1 -1.7
PJP Invesco Dynamic Pharmaceuticals ETF 22.6 56 -10 13.1 +12.6
IDNA iShares Genomics Immunology & Healthcare ETF 21.6 47 -1 -2.8 -3.3
LNGR Global X Longevity Thematic ETF 21.2 50 -4 3.2 +2.7
GDNA Goldman Sachs Motif Human Evolution ETF 19.5 50 -4 0.5 +0.0
FXH First Trust Health Care AlphaDEX Fund 19.0 62 -16 4.0 +3.4
FHLC Fidelity MSCI Health Care Index ETF 17.7 8 38 5.5 +5.0
QQXT First Trust Nasdaq-100 Ex-Technology Sector Index Fund 17.4 60 -14 3.7 +3.2
JHMH John Hancock Multifactor Healthcare ETF 17.4 40 6 6.2 +5.6
VHT Vanguard Health Care Index Fund 17.3 10 36 5.5 +4.9
BBC Virtus LifeSci Biotech Clinical Trials ETF 17.1 79 -33 0.0 -0.5
IYH iShares U.S. Healthcare ETF 15.9 43 3 6.2 +5.7
GNOM Global X Genomics & Biotechnology ETF 15.9 50 -4 -3.6 -4.1
HELX Franklin Genomic Advancements ETF 14.9 50 -4 -1.2 -1.8
IWO iShares Russell 2000 Growth ETF 14.7 24 22 -0.1 -0.7
CNCR Loncar Cancer Immunotherapy ETF 14.0 79 -33 -2.7 -3.2
RYH Invesco S&P 500 Equal Weight Health Care ETF 12.9 40 6 6.8 +6.3
VTWG Vanguard Russell 2000 Growth Index Fund 12.7 15 31 0.1 -0.5
ARKG ARK Genomic Revolution ETF 12.6 75 -29 -2.0 -2.5
XLV Health Care Select Sector SPDR Fund 11.7 13 33 7.2 +6.7
JKK iShares Morningstar Small-Cap Growth ETF 11.4 30 16 1.0 +0.5
ALFA AlphaClone Alternative Alpha ETF 11.3 65 -19 -0.5 -1.0
VBK Vanguard Small-Cap Growth Index Fund 11.2 7 39 2.2 +1.7
QQQJ Invesco NASDAQ Next Gen 100 ETF 11.1 15 31 3.6 +3.1
SBIO ALPS Medical Breakthroughs ETF 11.0 50 -4 -1.8 -2.3
QQEW First Trust Nasdaq-100 Equal Weighted Index Fund 10.4 59 -13 4.2 +3.7
QQQE Direxion NASDAQ-100 Equal Weighted Index Shares 10.3 35 11 4.5 +3.9
HTEC ROBO Global Healthcare Technology & Innovation ETF 10.3 68 -22 0.1 -0.4
FTCS First Trust Capital Strength ETF 10.3 58 -12 4.7 +4.2
FNY First Trust Mid Cap Growth AlphaDEX Fund 10.0 70 -24 2.1 +1.5
GERM ETFMG Treatments Testing and Advancements ETF 9.6 68 -22 -3.0 -3.5
MXDU Nationwide Maximum Diversification US Core Equity ETF 9.4 34 12 4.6 +4.0
PTH Invesco DWA Healthcare Momentum ETF 9.1 60 -14 -5.0 -5.5
CACG ClearBridge All Cap Growth ETF 9.0 54 -8 4.2 +3.6
IWM iShares Russell 2000 ETF 8.8 19 27 3.3 +2.8
VTWO Vanguard Russell 2000 Index Fund 8.6 10 36 3.5 +3.0
VFMO Vanguard U.S. Momentum Factor ETF 8.6 13 33 0.7 +0.2
VIRS Pacer BioThreat Strategy ETF 8.6 70 -24 4.5 +4.0
FCPI Fidelity Stocks for Inflation ETF 8.5 29 17 6.2 +5.7
XT iShares Exponential Technologies ETF 8.4 47 -1 4.8 +4.3
TECB iShares US Tech Breakthrough Multisector ETF 8.3 40 6 3.9 +3.4
SDG iShares Sustainable MSCI Global Impact ETF 8.2 49 -3 6.2 +5.6
SCHA Schwab U.S. Small-Cap ETF 8.2 4 42 4.7 +4.1
ESML iShares MSCI USA Small-Cap ESG Optimized ETF 8.2 17 29 4.7 +4.2
IHE iShares U.S. Pharmaceuticals ETF 8.1 42 4 5.4 +4.8
NUSC Nuveen ESG Small-Cap ETF 8.0 40 6 4.7 +4.2
PBSM Invesco PureBeta MSCI USA Small Cap ETF 8.0 6 40 5.0 +4.5
IXJ iShares Global Healthcare ETF 8.0 46 0 6.5 +5.9
QVAL Alpha Architect U.S. Quantitative Value ETF 7.9 49 -3 10.5 +10.0
XPH SPDR S&P Pharmaceuticals ETF 7.3 35 11 4.0 +3.5
FAD First Trust Multi Cap Growth AlphaDEX Fund 7.3 66 -20 2.2 +1.7
IWP iShares Russell Mid-Cap Growth ETF 7.2 24 22 2.9 +2.3
COWZ Pacer US Cash Cows 100 ETF 7.0 49 -3 11.5 +10.9
SZNE Pacer CFRA-Stovall Equal Weight Seasonal Rotation ETF 7.0 60 -14 6.4 +5.9
HIPR Direxion High Growth ETF 6.9 40 6 4.4 +3.9
SFYX Sofi Next 500 ETF 6.8 0 46 5.7 +5.2
RBUS Nationwide Risk-Based U.S. Equity ETF 6.8 30 16 4.6 +4.1
STSB iShares Factors US Small Blend Style ETF 6.6 35 11 3.6 +3.1
VB Vanguard Small-Cap ETF 6.6 5 41 5.2 +4.6
VXF Vanguard Extended Market Index Fund 6.6 6 40 3.5 +3.0
FDG American Century Focused Dynamic Growth ETF 6.5 45 1 1.6 +1.1
BKSE BNY Mellon US Small Cap Core Equity ETF 6.4 4 42 5.6 +5.1
BOSS Global X Founder-Run Companies ETF 6.4 45 1 3.2 +2.7
MTUM iShares Edge MSCI USA Momentum Factor ETF 6.3 15 31 4.1 +3.5
JHSC John Hancock Multifactor Small Cap ETF 6.3 42 4 5.5 +4.9
JSMD Janus Henderson Small/Mid Cap Growth Alpha ETF 6.2 30 16 5.5 +5.0
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 6.1 21 25 3.0 +2.5
PQSG PGIM QMA Strategic Alpha Small-Cap Growth ETF 6.1 29 17 0.2 -0.4
USVM VictoryShares USAA MSCI USA Small Cap Value Momentum ETF 5.9 24 22 6.4 +5.8
FNX First Trust Mid Cap Core AlphaDEX Fund 5.9 61 -15 6.3 +5.8
JKH iShares Morningstar Mid-Cap Growth ETF 5.9 30 16 2.0 +1.4
BBMC JPMorgan BetaBuilders U.S. Mid Cap Equity ETF 5.9 7 39 5.1 +4.5
QGRO American Century STOXX U.S. Quality Growth ETF 5.8 29 17 3.7 +3.2
GSSC Goldman Sachs Activebeta U.S. Small Cap Equity ETF 5.7 20 26 4.7 +4.2
FTXH First Trust Nasdaq Pharmaceuticals ETF 5.7 60 -14 11.9 +11.3
QQQN VictoryShares Nasdaq Next 50 ETF 5.5 18 28 3.0 +2.5
DIA SPDR Dow Jones Industrial Average ETF Trust 5.4 16 30 5.3 +4.8
PKW Invesco Buyback Achievers ETF 5.3 62 -16 6.7 +6.1
SCHM Schwab U.S. Mid-Cap ETF 5.2 4 42 5.9 +5.3
ARKK ARK Innovation ETF 5.2 75 -29 -2.4 -2.9
IPO Renaissance IPO ETF 5.2 60 -14 0.6 +0.1
BIBL Inspire ETF 5.2 35 11 4.7 +4.1
QVM Arrow QVM Equity Factor ETF 5.1 65 -19 4.8 +4.3
ENTR Entrepreneur 30 Fund 5.0 49 -3 1.2 +0.6
QYLD Global X NASDAQ 100 Covered Call ETF 4.9 60 -14 3.4 +2.9
LRGF iShares Edge MSCI Multifactor USA ETF 4.9 20 26 7.0 +6.5
DWAS Invesco DWA SmallCap Momentum ETF 4.9 60 -14 -2.0 -2.6
FCTR First Trust Lunt U.S. Factor Rotation ETF 4.8 65 -19 2.9 +2.3
QYLG Global X Nasdaq 100 Covered Call & Growth ETF 4.7 60 -14 3.4 +2.9
GURU Global X Guru Index ETF 4.7 75 -29 3.8 +3.2
VFMV Vanguard U.S. Minimum Volatility ETF 4.7 13 33 4.3 +3.7
MDYG SPDR S&P 400 Mid Cap Growth ETF 4.6 15 31 4.9 +4.4
FYC First Trust Small Cap Growth AlphaDEX Fund 4.6 70 -24 1.8 +1.3

1Overlap is the percentage of holdings by weight that are identical. For example, if Fund A has a 2% position in Apple, Inc. (AAPL) and Fund B has a 5% position, their overlapping position in AAPL is 2%.

Content on this tab for subscribers only**

RESULTS & ESTIMATES

  2015 2016 2017 2018 2019 2020E 2021E
Sales per share ** ** ** ** ** ** **
Earnings per share ** ** ** ** ** ** **
Dividends per share info ** ** ** ** ** ** **
Book value per share ** ** ** ** ** ** **

 

Sales per share growth   **% **% **% **% **% **%
EPS growth   **% **% **% **% **% **%

Sales per share growth   **% **% **% **% **% **%
EPS growth   **% **% **% **% **% **%

OTHER FUNDAMENTAL METRICS

Long term EPS growth est. **%   Debt-to-equity **x
Asset turnover **%   Assets-to-equity **x

Return on equity

Revision activity*
*Six months ago = 100

Net margins

Compound annual growth rates

Content on this tab for subscribers only

VALUATION METRICS
  2019 2020E 2021E
Price-to-sales ** ** **
Price-to-earnings ** ** **
Price-to-cash flow ** ** **
Price-to-growth ** ** **
Price-to-book value ** ** **
Yield ** ** **

Historical valuation trends

Forward
multiple:		 iShares NASDAQ Biotechnology ETF
Relative
to:		 S&P500 MSCI EAFE MSCI Emg. Mkts. Other ETF:

AVOID
Not worthwhile for most investors. A rating of AVOID is assigned to ETFs with ALTAR Scores in the lowest quintile (the bottom 20%) of their category. Often, funds in this category consist of stocks with little if any history or expectation of profitability, and as a result our fundamentally-driven analysis may not be relevant.

ALTAR Score™


Calculation of ALTAR Score™
Avg. Return on Equity 5.3 %
Divided by: Fwd. P/BV 5.4 x
Less: Expense ratio 46 bp
Equals: ALTAR Score 0.5 %
info More information on ALTAR Score™
MODERN PORTFOLIO THEORY info

CONSENSUS RECOMMENDATIONS: FUND CONSTITUENTS
COMPOSITE
RATING		 1.43 CATEGORY
AVERAGE		 1.51
 
The composite rating is a weighted average of analysts' consensus recommendations for individual ETF constituents, based on the following scale:

BUY = 1; OVERWEIGHT = 1.5, HOLD = 2; UNDERWEIGHT = 2.5; and SELL = 3.

Readers are cautioned that because analyst ratings tend to be inflated, the composite score may be more useful as a relative measure of sentiment between funds rather than as a stand-alone recommendation.
 

 

See RATING tab for calculation of ALTAR Score™
Risk & reward. Uses std. dev. as proxy for risk, ALTAR Score™ for return forecast.
Dividends paid by constituents to the fund. May differ from actual distributions to shareholders due to constituent changes, timing issues or other factors.
Monthly returns based on changes in price plus dividends. May differ from daily returns reported by funds. See below for standardized returns.